Tsp Capital Management Group, LLC Abb Vie Inc. Transaction History

Tsp Capital Management Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $436,242 - $545,832	-6,048 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $119,613 - $160,173	-1,300 Reduced 17.69%	6,048 $572,000
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $17,462 - $22,305	-250 Reduced 3.29%	7,348 $653,000
Q2 2017 Aug 08, 2017	BUY	N/A	7,598	7,598 $551,000

3,653

1.24B

15.5M

11.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Tsp Capital Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Tsp Capital Management Group, LLC with notifications on news.